Lentinan inhibits breast cancer cell growth through the dual downregulation of tumor-promoting effectors CD133 and SCGB2A2
- 11 March 2026
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 354, 151391
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (U23A20536)
- National Natural Science Foundation of China (82104299)
- National Natural Science Foundation of China (82074111)
- Science and Technology Program of Hubei Province (2025CCB010)
- Huazhong University of Science and Technology (2023JCYJ038)
This publication has 60 references indexed in Scilit:
- EdU sensing: The Raman way of following endothelial cell proliferation in vitro and ex vivoBiosensors and Bioelectronics, 2022
- Mammaglobin 1 mediates progression of trastuzumab‐resistant breast cancer cells through regulation of cyclins and NF‐κBFEBS Open Bio, 2022
- Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China2019
- Structure and antinociceptive effects of β- d -glucans from Cookeina tricholomaCarbohydrate Polymers, 2016
- (1→6)- and (1→3)(1→6)-β-glucans from Lasiodiplodia theobromae MMBJ: Structural characterization and pro-inflammatory activityCarbohydrate Polymers, 2015
- Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugsMolecular Carcinogenesis, 2015
- Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United StatesCancer, 2015
- Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cellsBreast Cancer Research and Treatment, 2005
- Dose Dependency of the Kinetics of Dextrans in Rats: Effects of Molecular WeightJournal of Pharmaceutical Sciences, 1995
- NMR Spectroscopy in the structural elucidation of oligosaccharides and glycosidesPhytochemistry, 1992